What the Nurtec ODT TV commercial - Hide in the Dark is about.
Nurtec ODT is a medication that is used to treat migraines. It is taken orally, and it is designed to dissolve quickly on the tongue. In a recent TV spot, Nurtec ODT teamed up with Khloé Kardashian to promote the medication.
The TV spot, titled "Hide in the Dark," opens with Khloé talking about her experience with migraines. She explains how her migraines made it difficult for her to do the things she loved, such as spending time with her family and working out. She describes how she would have to hide in the dark until the migraine subsided.
Khloé then explains how Nurtec ODT has helped her manage her migraines. She takes the medication, and within an hour, her migraine symptoms subside. The TV spot shows Khloé going about her day without any migraine pain, working out, spending time with her family, and enjoying life.
The commercial ends with Khloé telling viewers that they don't have to hide in the dark anymore. She encourages anyone who suffers from migraines to talk to their doctor about Nurtec ODT.
Overall, the TV spot is a powerful endorsement for Nurtec ODT. The partnership with Khloé Kardashian helps to raise awareness about the medication and the impact it can have on people's lives. By sharing her personal experience, Khloé helps to make the message relatable and encourages people who suffer from migraines to seek treatment.
Nurtec ODT TV commercial - Hide in the Dark produced for
Nurtec
was first shown on television on March 21, 2021.
Frequently Asked Questions about nurtec odt tv spot, 'hide in the dark' featuring khloé kardashian
Khloé Kardashian claims her migraines were debilitating and took away time she could have spent with her loved ones. She says she found relief with Nurtec. Nurtec is a prescribed oral medication intended to treat and prevent migraine symptoms when taken as directed.
Nurtec ODT has been found to be effective for acute treatment and prevention of migraine symptoms in adults.
This version of Khloé Kardashian is particularly dead-eyed. It's as if the people at Nurtec are holding her medicine hostage, forcing her to work through an intense migraine while reading cue cards just out of frame.
artist Lady Gaga
Pfizer recently launched a new TV commercial for its migraine medication, Nurtec ODT, featuring Grammy-winning artist Lady Gaga as the face of the campaign.
Calcitonin gene-related peptide (CGRP) is a protein that is released during migraine attacks, causing inflammation and activation of other pathophysiological processes responsible for pain. Rimegepant [Nurtec® ODT (USA); Vydura® (EU)] is an oral medication that works by blocking the CGRP receptors.
Nurtec ODT is a calcitonin gene-related peptide receptor antagonist. It reaches maximum plasma concentration 1.5 hours after oral administration and displays an elimination half-life of about 11 hours. It is metabolized primarily by cytochrome P450 3A4 and to a lesser extent by cytochrome P450 2C9.
Brand-name vs.
Nurtec ODT is only available as a brand-name drug. It doesn't come in a generic version. A generic drug is an exact copy of the active drug in a brand-name medication. Generics tend to cost less than brand-name drugs.
Nurtec is currently available as a brand-name orally disintegrating tablet (ODT) only. The generic name is rimegepant. The average retail price of Nurtec is $1,275.71 for 1, 8 Tablets Disintegrating Tablet Disintegrating.
Nurtec costs $1,259 without insurance. Learn how to get Nurtec at a lower price or find cheaper alternatives. Nurtec ODT (orally disintegrating tablet) is a brand-name prescription drug that helps prevent migraine headaches or relieve the symptoms of a migraine episode.
Pfizer Recalls Nurtec ODT Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning | CPSC.gov.
Nurtec ODT may cause serious side effects including allergic reactions, including trouble breathing and rash. This can happen days after you take Nurtec ODT. Call your HCP or get emergency help right away if you have swelling of the face, mouth, tongue, or throat or trouble breathing.
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Biohaven Pharmaceutical Holding Company Ltd., the maker of NURTEC® ODT (rimegepant), an innovative migraine therapy approved for both acute treatment and prevention of episodic migraine in adults.